Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 2Genitourinary 2Breast 2Sarcoma 1Other 1

Conditions

Lung Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1167Cisplatin 889Pemetrexed 845pembrolizumab 622Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 124Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Surgical Instruments × Thoracic × Clear all
NCT05478538 2026-04-29

CYBRID-01

Elephas

Active not recruiting
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05706883 2024-04-05

ProphetaPro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
348 enrolled
Thoracic

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡